Vogt-Koyanagi-Harada Syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine

The challenge of COVID-19 has rapidly changed medical management worldwide. The relatively small time from pandemic to vaccines regulatory approval triggered a race toward vaccines development. However, important questions regarding SARS-CoV-2 vaccines remain. A case of complete Vogt-Koyanagi-Harada...

Descripción completa

Detalles Bibliográficos
Autores principales: Saraceno, Janaína Jamile Ferreira, Souza, Guilherme Macedo, dos Santos Finamor, Luciana Peixoto, Nascimento, Heloisa Moraes, Belfort, Rubens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404022/
https://www.ncbi.nlm.nih.gov/pubmed/34462013
http://dx.doi.org/10.1186/s40942-021-00319-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404022/
https://www.ncbi.nlm.nih.gov/pubmed/34462013
http://dx.doi.org/10.1186/s40942-021-00319-3

Ejemplares similares